Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.
Stock Price Prediction
Update at 5:00pm EST
12.824 - 12.875
12.875 - 12.919
11.934 - 11.995
11.995 - 12.047
12.393 - 12.494
12.494 - 12.581
as of: 2019-12-12 4:32:03 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ITCI has closed below upper band by 0.9%. Bollinger Bands are 72.7% wider than normal. The large width of the bands suggest high volatility as compared to ITCI's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.
2019-11-19 Options Traders Expect Huge Moves in Intra-Cellular Therapies (ITCI) Stock Investors need to pay close attention to Intra-Cellular Therapies (ITCI) stock based on the movements in the options market lately.
2019-11-16 Analysts Expect Intra-Cellular Therapies Inc (NASDAQ:ITCI) Will Announce Earnings of -$0.91 Per Share Analysts forecast that Intra-Cellular Therapies Inc (NASDAQ:ITCI) will report earnings of ($0.91) per share for the current quarter, Zacks reports. Zero analysts have made estimates for Intra-Cellular Therapies’ earnings. The lowest EPS estimate is ($1.03) and the highest is ($0.78). Intra-Cellular Therapies reported earnings per share of ($0.75) in the same quarter last year, which […]
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.